Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Kaiser

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Blood|March 21, 2008
Tumor-specific Th17-polarized cells eradicate large established melanomaPawel Muranski, Andrea Boni, Paul A Antony, et al.
Nature Communications|March 6, 2021
Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinomaDaniel Schäfer, Stefan Tomiuk, Laura N Küster, et al.
Oncoimmunology|June 10, 2022
Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targetingChristian M Seitz, Joerg Mittelstaet, Daniel Atar, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Blood|March 21, 2008
Tumor-specific Th17-polarized cells eradicate large established melanomaPawel Muranski, Andrea Boni, Paul A Antony, et al.
Nature Communications|March 6, 2021
Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinomaDaniel Schäfer, Stefan Tomiuk, Laura N Küster, et al.
Oncoimmunology|June 10, 2022
Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targetingChristian M Seitz, Joerg Mittelstaet, Daniel Atar, et al.
Pageof 4